467 related articles for article (PubMed ID: 20177001)
1. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
2. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
4. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target.
Zhang ZH; Li J; Liu BR; Luo CF; Dong Q; Zhao LN; Zhong Y; Chen WY; Chen MS; Liu SM
J Cardiovasc Pharmacol; 2013 Sep; 62(3):312-9. PubMed ID: 23719092
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Song G; Zhu L; Ruan Z; Wang R; Shen Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
[TBL] [Abstract][Full Text] [Related]
11. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
[TBL] [Abstract][Full Text] [Related]
12. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
14. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression.
Wang C; Wang S; Zhao P; Wang X; Wang J; Wang Y; Song L; Zou Y; Hui R
J Cell Biochem; 2012 Jun; 113(6):2040-6. PubMed ID: 22275134
[TBL] [Abstract][Full Text] [Related]
15. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a.
Wei L; Yuan M; Zhou R; Bai Q; Zhang W; Zhang M; Huang Y; Shi L
J Cardiovasc Pharmacol; 2015 Apr; 65(4):357-63. PubMed ID: 25850725
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
18. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
